In vivo electroporation for gene therapy

Human Gene Therapy

Volumn 17, Issue 9, 2006, Pages 890-897

  Heller, Loree C ^b   Heller, Richard ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANGIOSTATIN; B7 ANTIGEN; BCG VACCINE; BLEOMYCIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ENDOSTATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH HORMONE RELEASING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 4; PEPTIDE FRAGMENT; PLASMID DNA; PROTEIN P53; RAPSYN; SMALL INTERFERING RNA; THYMIDINE KINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 4; TUMOR NECROSIS FACTOR RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASOSTATIN;

ARTHRITIS; CANCER; CANCER GENE THERAPY; CANCER INHIBITION; CANCER SURVIVAL; CARDIAC GRAFT REJECTION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIABETIC NEUROPATHY; ELECTROPORATION; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; GRAFT REJECTION; HUMAN; LIVER FIBROSIS; LUNG FIBROSIS; LUNG GRAFT REJECTION; MELANOMA; MONOTHERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REVIEW; SQUAMOUS CELL CARCINOMA; UVEITIS; GENE THERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; METHODOLOGY; NEOPLASM;

ELECTROPORATION; GENE THERAPY; INJECTIONS, INTRAMUSCULAR; NEOPLASMS;

EID: 33750626735     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.890     Document Type: Review

References (107)

1. ANDRE, F., and MIR, L.M. (2004). DNA electrotransfer: Its principles and an updated review of its therapeutic applications. Gene Ther. 11(Suppl. 1), S33-S42.
2. BLOQUEL, C., BESSIS, N., BOISSIER, M.C., SCHERMAN, D., and BIGEY, P. (2004). Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-α soluble receptor I variants. Hum. Gene Ther. 15, 189-201.
3. BLOQUEL, C., BEJJANI, R., BIGEY, P., BEDIOUI, F., DOAT, M., BENEZRA, D., SCHERMAN, D., and BEHAR-COHEN, F. (2006). Plasmid electrotransfer of eye ciliary muscle: Principles and therapeutic efficacy using hTNF-α soluble receptor in uveitis. FASEB J. 20, 389-391.
4. BROWN, P.A., DAVIS, W.C., and DRAGHIA-AKLI, R. (2004). Immune-enhancing effects of growth hormone-releasing hormone delivered by plasmid injection and electroporation. Mol. Ther. 10, 644-651.
5. BUREAU, M.F., GEHL, J., DELEUZE, V., MIR, L.M., and SCHERMAN, D. (2000). Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim. Biophys. Acta 1474, 353-359.
6. CASCANTE, A., HUCH, M., RODRIGUEZ, L.G., GONZALEZ, J.R., COSTANTINI, L., and FILLAT, C. (2005). Tat8-TK/GCV suicide gene therapy induces pancreatic tumor regression in vivo. Hum. Gene Ther. 16, 1377-1388.
7. CELIKER, M.Y., WANG, M., ATSIDAFTOS, E., LIU, X., LIU, Y.E., JIANG, Y., VALDERRAMA, E., GOLDBERG, I.D., and SHI, Y.E. (2001). Inhibition of Wilms' tumor growth by intramuscular administration of tissue inhibitor of metalloproteinases-4 plasmid DNA. Oncogene 20, 4337-4343.
8. CHI, C.H., WANG, Y.S., LAI, Y.S., and CHI, K.H. (2003). Anti-tumor effect of in vivo IL-2 and GM-CSF electrogene therapy in murine hepatoma model. Anticancer Res. 23, 315-321.
9. CHI, C.H., LIU, I.L., LO, W.Y., LIAW, B.S., WANG, Y.S., and CHI, K.H. (2005). Hepatocyte growth factor gene therapy prevents radiation-induced liver damage. World J. Gastroenterol. 11, 1496-1502.
10. CHI, K.H., WANG, H.E., WANG, Y.S., CHOU, S.L., YU, H.M., TSENG, Y.H., HWANG, I.M., and LUI, W.Y. (2004). Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model. J. Nucl. Med. 45, 478-484.
11. CICHON, T., JAMROZY, L., GLOGOWSKA, J., MISSOL-KOLKA, E., and SZALA, S. (2002). Electrotransfer of gene encoding endostatin into normal and neoplastic mouse tissues: Inhibition of primary tumor growth and metastatic spread. Cancer Gene Ther. 9, 771-777.
12. DOBASHI, M., GODA, K., MARUYAMA, H., and FUJISAWA, M. (2005). Erythropoietin gene transfer into rat testes by in vivo electroporation may reduce the risk of germ cell loss caused by cryptorchidism. Asian J. Androl. 7, 369-373.
13. DRAGHIA-AKLI, R., and SMITH, L.C. (2003). Electrokinetic enhancement of plasmid delivery in vivo. In: Templeton, N.S., and Lasic, D.D., eds. Gene Therapy: Therapeutic Mechanisms and Strategies (Marcel Dekker, New York) pp. 245-263.
14. DURIEUX, A.C., BONNEFOY, R., MANISSOLLE, C., and FREYSSENET, D. (2002). High-efficiency gene electrotransfer into skeletal muscle: Description and physiological applicability of a new pulse generator. Biochem. Biophys. Res. Commun. 296, 443-450.
15. DURIEUX, A.C., BONNEFOY, R., BUSSO, T., and FREYSSENET, D. (2004). In vivo gene electrotransfer into skeletal muscle: Effects of plasmid DNA on the occurrence and extent of muscle damage. J. Gene Med. 6, 809-816.
16. ELEZ, R., PIIPER, A., KRONENBERGER, B., KOCK, M., BRENDEL, M., HERMANN, E., PLIQUETT, U., NEUMANN, E., and ZEUZEM, S. (2003). Tumor regression by combination antisense therapy against Plk1 and Bcl-2. Oncogene 22, 69-80.
17. ENGSTRÖM, P.E. (1999). Electropermeabilization in experimental tumour treatment: Dosimetry and tissue effects. Ph.D. thesis, Lund University, Lund, Sweden.
18. FRANQUESA, M., ALPEROVICH, G., HERRERO-FRESNEDA, I., LLOBERAS, N., BOLANOS, N., FILLAT, C., RAMA, I., CRUZADO, J.M., GRINYO, J.M., and TORRAS, J. (2005). Direct electrotransfer of hHGF gene into kidney ameliorates ischemic acute renal failure. Gene Ther. 12, 1551-1558.
19. GILBERT, R., JAROSZESKI, M.J., HELLER, L., and HELLER, R. (2002). Electric field enhanced plasmid delivery to liver hepatocellular carcinomas. Technol. Cancer Res. Treat. 1, 355-364.
20. GOTHELF, A., MIR, L.M., and GEHL, J. (2003). Electrochemotherapy: Results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat. Rev. 29, 371-387.
21. GOTO, T., NISHI, T., TAMURA, T., DEV, S.B., TAKESHIMA, H., KOCHI, M., YOSHIZATO, K., KURATSU, J., SAKATA, T., HOFMANN, G.A., and USHIO, Y. (2000). Highly efficient electro-gene therapy of solid tumor by using an expression plasmid for the herpes simplex virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 97, 354-359.
22. GOTO, T., NISHI, T., KOBAYASHI, O., TAMURA, T., DEV, S.B., TAKESHIMA, H., KOCHI, M., KURATSU, J., SAKATA, T., and USHIO, Y. (2004). Combination electro-gene therapy using herpes virus thymidine kinase and interleukin-12 expression plasmids is highly efficient against murine carcinomas in vivo. Mol. Ther. 10, 929-937.
23. GOULD, D.J., BRIGHT, C., and CHERNAJOVSKY, Y. (2004). Inhibition of established collagen-induced arthritis with a tumour necrosis factor-α inhibitor expressed from a self-contained doxycycline regulated plasmid. Arthritis Res. Ther. 6, R103-R113.
24. GROSSIN, L., COURNIL-HENRIONNET, C., PINZANO, A., GABORIT, N., DUMAS, D., ETIENNE, S., STOLTZ, J.F., TERLAIN, B., NETTER, P., MIR, L.M., and GILLET, P. (2006). Gene transfer with HSP 70 in rat chondrocytes confers cytoprotection in vitro and during experimental osteoarthritis. FASEB J. 20, 65-75.
25. HANNA, E., ZHANG, X., WOODLIS, J., BREAU, R., SUEN, J., and LI, S. (2001). Intramuscular electroporation delivery of IL-12 gene for treatment of squamous cell carcinoma located at distant site. Cancer Gene Ther. 8, 151-157.
26. Kip1 gene following in vivo electroporation. Oncol. Rep. 13, 201-206.
27. HARADA, N., SHIMADA, M., OKANO, S., SUEHIRO, T., SOEJIMA, Y., TOMITA, Y., and MAEHARA, Y. (2004). IL-12 gene therapy is an effective therapeutic strategy for hepatocellular carcinoma in immunosuppressed mice. J. Immunol. 173, 6635-6644.
28. HELLER, L., JAROSZESKI, M.J., COPPOLA, D., POTTINGER, C., GILBERT, R., and HELLER, R. (2000a). Electrically mediated plasmid DNA delivery to hepatocellular carcinomas in vivo. Gene Ther. 7, 826-829.
29. HELLER, L., POTTINGER, C., JAROSZESKI, M.J., GILBERT, R., and HELLER, R. (2000b). In vivo electroporation of plasmids encoding GM-CSF or interleukin-2 into existing B16 melanomas combined with electrochemotherapy induces longterm antitumour immunity. Melanoma Res. 10, 577-583.
30. HELLER, L., MERKLER, K., WESTOVER, J., CRUZ, Y., COPPOLA, D., BENSON, K., DAUD, A.I., and HELLER, R (2006). Evaluation of toxicity following electrically mediated interleukin-12 gene delivery in a B16 mouse melanoma model. Clin. Cancer Res. 12, 3177-3183.
31. HELLER, L.C., UGEN, K., and HELLER, R. (2005). Electroporation for targeted gene transfer. Exp. Opin. Drug Deliv. 2, 255-268.
32. HELLER, L.C., INGRAM, S.F., LUCAS, M.L., GILBERT, R.A., and HELLER, R. (2002). Effect of electrically mediated intratumor and intramuscular delivery of a plasmid encoding IFN-α on visible B16 mouse melanomas. Technol. Cancer Res. Treat. 1, 205-209.
33. HELLER, R. (2003). Delivery of plasmid DNA using in vivo electroporation. Preclinica 1, 198-208.
34. HELLER, R., JAROSZESKI, M., ATKIN, A., MORADPOUR, D., GILBERT, R., WANDS, J., and NICOLAU, C. (1996). In vivo gene electroinjection and expression in rat liver. FEBS Lett. 389, 225-228.
35. HO, S.H., HAHN, W., LEE, H.J., KIM, D.S., JEONG, J.G., KIM, S., YU, S.S., JEON, E.S., KIM, S., and KIM, J.M. (2004). Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4. Biochem. Biophys. Res. Commun. 321, 759-766.
36. HO, S.H., LEE, H.J., KIM, D.S., JEONG, J.G., KIM, S., YU, S.S., JIN, Z., KIM, S., and KIM, J.M. (2006). Intrasplenic electro-transfer of IL-4 encoding plasmid DNA efficiently inhibits rat experimental allergic encephalomyelitis. Biochem. Biophys. Res. Commun. 343, 816-824.
37. HUNG, K.S., LEE, T.H., CHOU, W.Y., WU, C.L., CHO, C.L., LU, C.N., JAWAN, B., and WANG, C.H. (2005). Interleukin-10 gene therapy reverses thioacetamide-induced liver fibrosis in mice. Biochem. Biophys. Res. Commun. 336, 324-331.
38. INOUE, A., TAKAHASHI, K.A., MAZDA, O., TERAUCHI, R., ARAI, Y., KISHIDA, T., SHIN-YA, M., ASADA, H., MORIHARA, T., TONOMURA, H., OHASHI, S., KAJIKAWA, Y., KAWAHITO, Y., IMANISHI, J., KAWATA, M., and KUBO, T. (2005). Electrotransfer of small interfering RNA ameliorated arthritis in rats. Biochem. Biophys. Res. Commun. 336, 903-908.
39. ISHIKAWA, H., TAKANO, M., MATSUMOTO, N., SAWADA, H., IDE, C., MIMURA, O., and DEZAWA, M. (2005). Effect of GDNF gene transfer into axotomized retinal ganglion cells using in vivo electroporation with a contact lens-type electrode. Gene Ther. 12, 289-298.
40. JAICHANDRAN, S., YAP, S.T., KHOO, A.B., HO, L.P., TIEN, S.L., and KON, O.L. (2006). In vivo liver electroporation: Optimization and demonstration of therapeutic efficacy. Hum. Gene Ther. 17, 362-375.
41. JAZOWIECKA-RAKUS, J., JAROSZ, M., and SZALA, S. (2006). Combination of vasostatin gene therapy with cyclophosphamide inhibits growth of B16(F10) melanoma tumours. Acta Biochim. Pol. 53, 199-202.
42. JEONG, J.G., KIM, J.M., HO, S.H., HAHN, W., YU, S.S., and KIM, S. (2004). Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis. J. Gene Med. 6, 1125-1133.
43. KHAN, A.S., ANSCOMBE, I.W., CUMMINGS, K.K., POPE, M.A., SMITH, L.C., and DRAGHIA-AKLI, R. (2003). Effects of plasmid-mediated growth hormone-releasing hormone supplementation on LL-2 adenocarcinoma in mice. Mol. Ther. 8, 459-466.
44. KISHIDA, T., ASADA, H., SATOH, E., TANAKA, S., SHINYA, M., HIRAI, H., IWAI, M., TAHARA, H., IMANISHI, J., and MAZDA, O. (2001). In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Ther. 8, 1234-1240.
45. KISHIDA, T., ASADA, H., ITOKAWA, Y., YASUTOMI, K., SHINYA, M., GOJO, S., CUI, F.D., UEDA, Y., YAMAGISHI, H., IMANISHI, J., and MAZDA, O. (2003). Electrochemo-gene therapy of cancer: Intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol. Ther. 8, 738-745.
46. KURODA, T., MARUYAMA, H., SHIMOTORI, M., HIGUCHI, N., KAMEDA, S., TAHARA, H., MIYAZAKI, J., and GEJYO, F. (2006). Effects of viral interleukin 10 introduced by in vivo electroporation on arthrogen-induced arthritis in mice. J. Rheumatol. 33, 455-462.
47. LEE, C.F., CHANG, S.Y., HSIEH, D.S., and YU, D.S. (2004). Treatment of bladder carcinomas using recombinant BCG DNA vaccines and electroporative gene immunotherapy. Cancer Gene Ther. 11, 194-207.
48. LEE, S.C., WU, C.J., WU, P.Y., HUANG, Y.L., WU, C.W., and TAO, M.H. (2003). Inhibition of established subcutaneous and metastatic murine tumors by intramuscular electroporation of the interleukin-12 gene. J. Biomed. Sci. 10, 73-86.
49. LEE, T.H., JAWAN, B., CHOU, W.Y., LU, C.N., WU, C.L., KUO, H.M., CONCEJERO, A.M., and WANG, C.H. (2006). α-Melanocyte-stimulating hormone gene therapy reverses carbon tetrachloride induced liver fibrosis in mice. J. Gene Med. 8, 764-772.
50. LI, S., ZHANG, X., XIA, X., ZHOU, L., BREAU, R., SUEN, J., and HANNA, E. (2001). Intramuscular electroporation delivery of IFN-α gene therapy for inhibition of tumor growth located at a distant site. Gene Ther. 8, 400-407.
51. LI, S., XIA, X., ZHANG, X., and SUEN, J. (2002a). Regression of tumors by IFN-α electroporation gene therapy and analysis of the responsible genes by cDNA array. Gene Ther. 9, 390-397.
52. LI, S., ZHANG, X., and XIA, X. (2002b). Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. J. Natl. Cancer Inst. 94, 762-768.
53. LI, S., ZHANG, L., TORRERO, M., CANNON, M., and BARRET, R. (2005). Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer. Mol. Ther. 12, 942-949.
54. LIU, F., and HUANG, L. (2002). A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol. Ther. 5, 323-328.
55. LIU, F., HESTON, S., SHOLLENBERGER, L.M., SUN, B., MICKLE, M., LOVELL, M., and HUANG, L. (2006). Mechanism of in vivo DNA transport into cells by electroporation: Electrophoresis across the plasma membrane may not be involved. J. Gene Med. 8, 353-361.
56. LOHR, F., LO, D.Y., ZAHAROFF, D.A., HU, K., ZHANG, X., LI, Y., ZHAO, Y., DEWHIRST, M.W., YUAN, F., and LI, C.Y. (2001). Effective tumor therapy with plasmid-encoded cytokines combined with in vivo electroporation. Cancer Res. 61, 3281-3284.
57. LONG, Y.C., JAICHANDRAN, S., HO, L.P., TIEN, S.L., TAN, S.Y., and KON, O.L. (2005). FVIII gene delivery by muscle electroporation corrects murine hemophilia A. J. Gene Med. 7, 494-505.
58. LOSEN, M., STASSEN, M.H., MARTINEZ-MARTINEZ, P., MACHIELS, B.M., DUIMEL, H., FREDERIK, P., VELDMAN, H., WOKKE, J.H., SPAANS, F., VINCENT, A., and DE BAETS, M.H. (2005). Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain 128, 2327-2337.
59. LUCAS, M.L., and HELLER, R. (2001). Immunomodulation by electrically enhanced delivery of plasmid DNA encoding IL-12 to murine skeletal muscle. Mol. Ther. 3, 47-53.
60. LUCAS, M.L., and HELLER, R. (2003). IL-12 gene therapy using an electrically mediated nonviral approach reduces metastatic growth of melanoma. DNA Cell Biol. 22, 755-763.
61. LUCAS, M.L., HELLER, L., COPPOLA, D., and HELLER, R. (2002). IL-12 plasmid delivery by in vivo electroporation for the successful treatment of established subcutaneous B16.F10 melanoma. Mol. Ther. 5, 668-675.
62. 1 subunit using electroporation increases lung liquid clearance. Am. J. Respir. Crit. Care Med. 171, 204-211.
63. MATSUBARA, H., GUNJI, Y., MAEDA, T., TASAKI, K., KOIDE, Y., ASANO, T., OCHIAI, T., SAKIYAMA, S., and TAGAWA, M. (2001). Electroporation-mediated transfer of cytokine genes into human esophageal tumors produces anti-tumor effects in mice. Anticancer Res. 21, 2501-2503.
64. MIKATA, K., UEMURA, H., OHUCHI, H., OHTA, S., NAGASHIMA, Y., and KUBOTA, Y. (2002). Inhibition of growth of human prostate cancer xenograft by transfection of p53 gene: Gene transfer by electroporation. Mol. Cancer Ther. 1, 247-252.
65. MIR, L.M., BUREAU, M.F., GEHL, J., RANGARA, R., ROUY, D., CAILLAUD, J.M., DELAERE, P., BRANELLEC, D., SCHWARTZ, B., and SCHERMAN, D. (1999). High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. U.S.A. 96, 4262-4267.
66. MITRUS, I., MISSOL-KOLKA, E., PLUCIENNICZAK, A., and SZALA, S. (2005). Tumour therapy with genes encoding apoptin and E4orf4. Anticancer Res. 25, 1087-1090.
67. MIYAHARA, T., KOYAMA, H., MIYATA, T., SHIGEMATSU, H., INOUE, J., TAKATO, T., and NAGAWA, H. (2006). Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery. J. Vasc. Surg. 43, 592-600.
68. MURAKAMI, T., ARAI, M., SUNADA, Y., and NAKAMURA, A. (2006). VEGF 164 gene transfer by electroporation improves diabetic sensory neuropathy in mice. J. Gene Med. 8, 773-781.
69. NEUMANN, E., SCHAEFER-RIDDER, M., WANG, Y., and HOFSCHNEIDER, P.H. (1982). Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J. 1, 841-845.
70. NEUMANN, E., KAKORIN, S., and TOENSING, K. (1999). Fundamentals of electroporative delivery of drugs and genes. Bioelectrochem. Bioenerg. 48, 3-16.
71. NISHI, T., YOSHIZATO, K., YAMASHIRO, S., TAKESHIMA, H., SATO, K., HAMADA, K., KITAMURA, I., YOSHIMURA, T., SAYA, H., KURATSU, J., and USHIO, Y. (1996). High-efficiency in vivo gene transfer using intraarterial plasmid DNA injection following in vivo electroporation. Cancer Res. 56, 1050-1055.
72. NIU, G., HELLER, R., CATLETT-FALCONE, R., COPPOLA, D., JAROSZESKI, M., DALTON, W., JOVE, R., and YU, H. (1999). Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res. 59, 5059-5063.
73. OKINO, M., MARUMOTO, M., KANESADA, H., KUGA, K., and MOHRI, H. (1987). Electrical impulse chemotherapy for rat solid tumors. In: Proceedings of the Japanese Cancer Association 46th Annual Meeting, September 7-9, 1987. Jpn. J. Cancer Res. 46, 420.
74. PEREZ, N., BIGEY, P., SCHERMAN, D., DANOS, O., PIECHACZYK, M., and PELEGRIN, M. (2004). Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation. Genet. Vaccines Ther. 2, 2.
75. PIEROG, J., GAZDHAR, A., STAMMBERGER, U.. GUGGER, M., HYDE, S., MATHIESEN, I., GRODZKI, T., and SCHMID, R.A. (2005). Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation. Eur. J. Cardiothorac. Surg. 27, 1030-1035.
76. PLIQUETT, U.F., GUSBETH, C.A., and WEAVER, J.C. (2000). Non-linearity of molecular transport through human skin due to electric stimulus. J. Control. Release 68, 373-386.
77. PRUD'HOMME, G.J., GLINKA, Y., KHAN, A.S., and DRAGHIAAKLI, R. (2006). Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr. Gene Ther. 6, 243-273.
78. PUC, M., COROVIC, S., FLISAR, K., PETKOVSEK, M., NASTRAN, J., and MIKLAVCIC, D. (2004). Techniques of signal generation required for electropermeabilization: Survey of electropermeabilization devices. Bioelectrochemistry 64, 113-124.
79. SATKAUSKAS, S., BUREAU, M.F., PUC, M., MAHFOUDI, A., SCHERMAN, D., MIKLAVCIC, D., and MIR, L.M. (2002). Mechanisms of in vivo DNA electrotransfer: Respective contributions of cell electropermeabilization and DNA electrophoresis. Mol. Ther. 5, 133-140.
80. SATKAUSKAS, S., ANDRE, F., BUREAU, M.F., SCHERMAN, D., MIKLAVCIC, D., and MIR, L.M. (2005). Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum. Gene Ther. 16, 1194-1201.
81. SCHIFFELERS, R.M., XU, J., STORM, G., WOODLE, M.C., and SCARIA, P.V. (2005). Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. Arthritis Rheum. 52, 1314-1318.
82. SHIBATA, M.A., MORIMOTO, J., and OTSUKI, Y. (2002). Suppression of murine mammary carcinoma growth and metastasis by HSVtk/GCV gene therapy using in vivo electroporation. Cancer Gene Ther. 9, 16-27.
83. SHIBATA, M.A., MORIMOTO, J., ITO, Y., KUSAKABE, K., and OTSUKI, Y. (2004). Experimental gene therapy in mammary and urinary bladder cancer using electrogene transfer. Med. Electron Microsc. 37, 216-224.
84. SHIBATA, M.A., MIWA, Y., MIYASHITA, M., MORIMOTO, J., ABE, H., and OTSUKI, Y. (2005). Electrogene transfer of an Epstein-Barr virus-based plasmid replicon vector containing the diphtheria toxin A gene suppresses mammary carcinoma growth in SCID mice. Cancer Sci. 96, 434-440.
85. SHIBATA, M.A., ITO, Y., MORIMOTO, J., KUSAKABE, K., YOSHINAKA, R., and OTSUKI, Y. (2006). In vivo electrogene transfer of interleukin-12 inhibits tumor growth and lymph node and lung metastases in mouse mammary carcinomas. J. Gene Med. 8, 335-352.
86. SHIMAO, K., TAKAYAMA, T., ENOMOTO, K., SAITO, T., NAGAI, S., MIYAZAKI, J., OGAWA, K., and TAHARA, H. (2005). Cancer gene therapy using in vivo electroporation of Flt3-ligand. Int. J. Oncol. 27, 457-463.
87. SLACK, A., BOVENZI, V., BIGEY, P., IVANOV, M.A., RAMCHANDANI, S., BHATTACHARYA, S., TENOEVER, B., LAMRIHI, B., SCHERMAN, D., and SZYF, M. (2002). Antisense MBD2 gene therapy inhibits tumorigenesis. J. Gene Med. 4, 381-389.
88. SODEN, D.M., LARKIN, J.O., COLLINS, C.G., TANGNEY, M., AARONS, S., PIGGOTT, J., MORRISSEY, A., DUNNE, C., and O'SULLIVAN, G.C. (2006). Successful application of targeted electrochemotherapy using novel flexible electrodes and low dose bleomycin to solid tumours. Cancer Lett. 232, 300-310.
89. SUKHAREV, S.I., KLENCHIN, V.A., SEROV, S.M., CHERNOMORDIK, L.V., and CHIZMADZHEV, Y.A. (1992). Electroporation and electrophoretic DNA transfer into cells: The effect of DNA interaction with electropores. Biophys. J. 63, 1320-1327.
90. TAKABATAKE, Y., ISAKA, Y., MIZUI, M., KAWACHI, H., SHIMIZU, F., ITO, T., HORI, M., and IMAI, E. (2005). Exploring RNA interference as a therapeutic strategy for renal disease. Gene Ther. 12, 965-973.
91. TAMURA, T., NISHI, T., GOTO, T., TAKESHIMA, H., DEV, S.B., USHIO, Y., and SAKATA, T. (2001). Intratumoral delivery of interleukin 12 expression plasmids with in vivo electroporation is effective for colon and renal cancer. Hum. Gene Ther. 12, 1265-1276.
92. TAMURA, T., NISHI, T., GOTO, T., TAKESHIMA, H., USHIO, Y., and SAKATA, T. (2003). Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth. Anticancer Res. 23, 1173-1179.
93. TANAKA, S., SUGIMACHI, K., YAMASHITA YI, Y., OHGA, T., SHIRABE, K., SHIMADA, M., WANDS, J.R., and SUGIMACHI, K. (2002). Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma. Hepatology 35, 861-867.
94. TANGNEY, M., CASEY, G., LARKIN, J.O., COLLINS, C.G., SODEN, D., CASHMAN, J., WHELAN, M.C., and O'SULLIVAN, G.C. (2006). Non-viral in vivo immune gene therapy of cancer: Combined strategies for treatment of systemic disease. Cancer Immunol. Immunother. 55, 1443-1450.
95. TAVAKOLI, R., GAZDHAR, A., PIEROG, J., BOGDANOVA, A., GUGGER, M., PRINGLE, I.A., GILL, D.R., HYDE, S.C., GENONI, M., and SCHMID, R.A. (2006). Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts. J. Gene Med. 8, 242-248.
96. TJELLE, T.E., CORTHAY, A., LUNDE, E., SANDLIE, I., MICHAELSEN, T.E., MATHIESEN, I., and BOGEN, B. (2004). Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol. Ther. 9, 328-336.
97. TORRERO, M.N., HENK, W.G., and LI, S. (2006). Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogene therapy. Clin. Cancer Res. 12, 257-263.
98. UESATO, M., GUNJI, Y., TOMONAGA, T., MIYAZAKI, S., SHIRATORI, T., MATSUBARA, H., KOUZU, T., SHIMADA, H., NOMURA, F., and OCHIAI, T. (2004). Synergistic antitumor effect of antiangiogenic factor genes on colon 26 produced by low-voltage electroporation. Cancer Gene Ther. 11, 625-632.
99. UGEN, K.E., KUTZLER, M.A., MARRERO, B., WESTOVER, J., COPPOLA, D., WEINER, D.B., and HELLER, R. (2006). Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation. Cancer Gene Ther. (June 9; Epub ahead of print).
100. WANG, C.H., LEE, T.H., LU, C.N., CHOU, W.Y., HUNG, K.S., CONCEJERO, A.M., and JAWAN, B. (2006). Electroporative α-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation. Gene Ther. 13, 1000-1009.
101. WANG, X.D., LIU, J., YANG, J.C., CHEN, W.Q., and TANG, J.G. (2003). Mice body weight gain is prevented after naked human leptin cDNA transfer into skeletal muscle by electroporation. J. Gene Med. 5, 966-976.
102. WOLFF, J.A., MALONE, R.W., WILLIAMS, P., CHONG, W., ACSADI, G., JANI, A., and FELGNER, P.L. (1990). Direct gene transfer into mouse muscle in vivo. Science 247, 1465-1468.
103. XIANG, L., MURAI, A., SUGAHARA, K., YASUI, A., and MURAMATSU, T. (2003). Effects of leptin gene expression in mice in vivo by electroporation and hydrodynamics-based gene delivery. Biochem. Biophys. Res. Commun. 307, 440-445.
104. YAMASHITA, Y., SHIMADA, M., HASEGAWA, H., MINAGAWA, R., RIKIMARU, T., HAMATSU, T., TANAKA, S., SHIRABE, K., MIYAZAKI, J., and SUGIMACHI, K. (2001). Electroporation-mediated interleukin-12 gene therapy for hepatocellular carcinoma in the mice model. Cancer Res. 61, 1005-1012.
105. YAMASHITA, Y., SHIMADA, M., TANAKA, S., OKAMAMOTO, M., MIYAZAKI, J., and SUGIMACHI, K. (2002). Electroporation-mediated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/Apo2L gene therapy for hepatocellular carcinoma. Hum. Gene Ther. 13, 275-286.
106. YOSHIZATO, K., NISHI, T., GOTO, T., DEV, S.B., TAKESHIMA, H., KINO, T., TADA, K., KIMURA, T., SHIRAISHI, S., KOCHI, M., KURATSU, J.I., HOFMANN, G.A., and USHIO, Y. (2000). Gene delivery with optimized electroporation parameters shows potential for treatment of gliomas. Int. J. Oncol. 16, 899-905.
107. ZAMPAGLIONE, I., ARCURI, M., CAPPELLETTI, M., CILIBERTO, G., PERRETTA, G., NICOSIA, A., LA MONICA, N., and FATTORI, E. (2005). In vivo DNA gene electro-transfer: A systematic analysis of different electrical parameters. J. Gene Med. 7, 1475-1481.